Company Overview of Teva Biopharmaceuticals USA, Inc.
Teva Biopharmaceuticals USA, Inc. engages in the discovery and development of biopharmaceuticals and long-acting medicines for various therapeutic areas. It offers HSA-fusion peptides and proteins for various diseases, including cancer, cardiovascular, metabolic, infectious, autoimmune, and CNS diseases. The company was formerly known as CoGenesys, Inc. and changed its name to Teva Biopharmaceuticals USA, Inc. in February 2008 following its acquisition by Teva Pharmaceutical Industries Limited. The company was founded in 2005 and is based in Rockville, Maryland. As of February 21, 2008, Teva Biopharmaceuticals USA, Inc. operates as a subsidiary of Teva Pharmaceutical Industries Ltd.
9410 Key West Avenue
Rockville, MD 20850-3345
Founded in 2005
Key Executives for Teva Biopharmaceuticals USA, Inc.
Similar Private Companies By Industry
|Proventiv Therapeutics, L.L.C.||United States|
|iviGene Corporation||United States|
|Orasense, Ltd.||United States|
|Cosmederm Bioscience, Inc.||United States|
|Merz North America, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Teva Biopharmaceuticals USA, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.